抄録
A quality test was examined on five kalliginogenase preparations and one of their raw materials. And clinical use of these preparations was investigated from the prescriptions of three months in the outpatients of this hospital.
Kinin-liberating activity and kininase activity were measured by the enzyme immunoassay (EIA) utilizing a bradykinin (BK). Kinin-liberating activity was 260-540ng BK/min/U, and kininase activity that was an indicator of impurity was less than 5Ong BK/min/U in all preparations. The result by the enzymatic method (BAEE) that was already reported by us was related very well to the kinin-liberating activity by the EIA method.
© 一般社団法人 日本医療薬学会